GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors

ABSTRACT: To evaluate the safety and anti-tumor activity of GEN1042 in patients with metastatic or locally advanced solid tumors.

DISEASE(S): Squamous Cell Carcinoma Of Head And Neck,Pancreatic Ductal Adenocarcinoma (pdac),Colorectal Cancer (crc),Malignant Solid Tumor,Malignant Solid Tumors: patients With Relapsed Or Refractory, Advanced And/or Metastatic Melanoma, Non-small Cell Lung Cancer (nsclc) Or Colorectal Cancer (crc) Who Are Not Anymore Candidates For Standard Therapy,Melanoma,Non Small Cell Lung Cancer (nsclc),Malignant Solid Tumors:patients With Relapsed Or Refractory, Advanced And/or Metastatic Melanoma, Non-small Cell Lung Cancer (nsclc) Or Colorectal Cancer (crc) Who Are Not Anymore Candidates For ...,Head And Neck Squamous Cell Carcinoma (hnscc),Malignant Solid Tumour,Neoplasms

PROVIDER: 2315820 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR